About 30% of individuals facing serious health-related suffering are affected by cancer (Figure 38.1). Cancer pain remains a common and distressing symptom both during treatment and in survivorship, affecting approximately half of all cancer patients and two-thirds of those with advanced disease.
Search
—
Results
"VIPREG2024 1xbet free promo code 2024 Papua New Guinea"
People are living longer after a cancer diagnosis due to advances in early detection and treatment. There are close to 54 million people worldwide who are currently diagnosed with a cancer diagnosis within five years (Figure 31.1).
Population-based cancer registries (PBCRs) are an essential foundation for the development and monitoring of national cancer-control plans, informing the planning of cancer services, and assessing the effectiveness of cancer-care delivery through benchmarking survival in different populations. PBCRs represent a continual system of data collection, storage, validation, and analysis, with the1
Liver cancer is the sixth most frequently occurring cancer in the world, but due to the poor prognosis associated with the disease, it is the third largest contributor to cancer mortality, with an estimated 870,000 cases and 760,000 deaths in 2022 (Map 18.1).
Cancer survival statistics highlight the degree of health care equity, reflecting the effectiveness of health systems in detecting, diagnosing, and treating cancers. Despite advancements in diagnostics and treatment, substantial disparities persist in international cancer survival both between and within countries due to inequality in the dissemination of advancements in diagnostic1
Northern Africa, Central and West Asia is a diverse region characterized by relatively low but increasing cancer incidence rates. Breast cancer is the most common cancer in both sexes combined in all countries but Egypt (liver cancer), Kyrgyzstan and Tajikistan (stomach cancer), and Azerbaijan, Armenia, Tunisia, Türkiye (lung cancer) (Map1
Costs of new cancer treatments have grown exponentially and patients are treated longer with more agents, increasing the economic burden for patients and families, health care systems, and countries. The economic burden of cancer also includes indirect costs, measured as productivity losses from cancer morbidity and premature mortality, and productivity1
Editors Ahmedin Jemal, DVM, PhD, American Cancer Society Hyuna Sung, PhD, American Cancer Society Kieran Kelly, MPH, American Cancer Society Isabelle Soerjomataram, MD, PhD, International Agency for Research on Cancer Freddie Bray, MSc, PhD, International Agency for Research on Cancer
The continuing and escalating global fight against cancer demands new tools and the latest available data and trends. The Cancer Atlas website and The Cancer Atlas, Fourth Edition book – produced by the American Cancer Society and the International Agency for Research on Cancer – provide a comprehensive global overview1
Each country has opportunities to prevent and control cancer through resource-stratified evidence-based interventions across the entire cancer care continuum, from risk factor prevention, early detection and timely diagnosis, to quality treatment, survivorship, palliative care, and end-of-life care (Figure 32.1).